EGFR exon 19 deletion + KRAS mutation

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer	EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer	erlotinib Sensitive: C3 – Early Trials erlotinib Sensitive : C3	erlotinib Sensitive: C3 – Early Trials erlotinib Sensitive : C3
EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer	EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3

Associations